Hamps Bio shares debuted on BSE SME at ₹96.90, 90% above the issue price of ₹51, and were locked in a 5% upper circuit. The ...

According to market observers, shares of the company are available at a premium of ₹46 in the grey market today ...

The initial share sale of Hamps Bio Ltd. saw a massive demand from investors during the three-day subscription period.

The pharma company, which received bids worth ₹6,242.5 crore for its ₹6.22 crore issue, is the third most subscribed SME IPO ...

The grey market premium (GMP) of Hamps Bio IPO was Rs 45 on December 17, climbing from Rs 35 when the issue opened for ...

The unlisted shares of Hamps Bio were trading at Rs 106, reflecting a grey market premium (GMP) of Rs 55, or 107.84 per cent ...

Hamps Bio shares were listed - at a 90% premium over the IPO price - on BSE SME platform today. The IPO which closed on ...

The Hamps Bio IPO has a total size of Rs 6.22 crores, with the entire issue consisting of a fresh offering of 12.2 lakh ...

After listing, the Hamps Bio shares gained an additional 5 per cent, surging 99.49 per cent from the issue price to reach the ...

Hamps Bio’s IPO launched on December 13, attracting significant interest with 6.48 times subscription. Retail investors ...

Hamps Bio IPO sees a 1,057 times subscription on the final day of bidding. Discover more about this strong market debut!

Hamps Bio’s shares soar with a 90% premium debut on BSE SME; IPO oversubscribed 1000 times, showcasing robust investor ...